FI20075417A0 - Formulationer och förfaranden för odling av embryonala stamceller - Google Patents

Formulationer och förfaranden för odling av embryonala stamceller

Info

Publication number
FI20075417A0
FI20075417A0 FI20075417A FI20075417A FI20075417A0 FI 20075417 A0 FI20075417 A0 FI 20075417A0 FI 20075417 A FI20075417 A FI 20075417A FI 20075417 A FI20075417 A FI 20075417A FI 20075417 A0 FI20075417 A0 FI 20075417A0
Authority
FI
Finland
Prior art keywords
formulations
methods
stem cells
embryonic stem
culturing embryonic
Prior art date
Application number
FI20075417A
Other languages
English (en)
Finnish (fi)
Inventor
Marjo-Riitta Suuronen
Kristiina Rajala
Outi Hovatta
Heli Skottman
Original Assignee
Marjo-Riitta Suuronen
Kristiina Rajala
Outi Hovatta
Heli Skottman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marjo-Riitta Suuronen, Kristiina Rajala, Outi Hovatta, Heli Skottman filed Critical Marjo-Riitta Suuronen
Priority to FI20075417A priority Critical patent/FI20075417A0/sv
Publication of FI20075417A0 publication Critical patent/FI20075417A0/sv
Priority to JP2010510839A priority patent/JP2010528642A/ja
Priority to KR1020107000131A priority patent/KR20100025569A/ko
Priority to PCT/FI2008/050331 priority patent/WO2008148938A1/en
Priority to EP08761727A priority patent/EP2155859A4/en
Priority to CA002689321A priority patent/CA2689321A1/en
Priority to AU2008259726A priority patent/AU2008259726A1/en
Priority to US12/632,057 priority patent/US20100081200A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
FI20075417A 2007-06-05 2007-06-05 Formulationer och förfaranden för odling av embryonala stamceller FI20075417A0 (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FI20075417A FI20075417A0 (sv) 2007-06-05 2007-06-05 Formulationer och förfaranden för odling av embryonala stamceller
JP2010510839A JP2010528642A (ja) 2007-06-05 2008-06-04 胚幹細胞の培養処方および方法
KR1020107000131A KR20100025569A (ko) 2007-06-05 2008-06-04 배아 줄기 세포 배양을 위한 제형 및 방법
PCT/FI2008/050331 WO2008148938A1 (en) 2007-06-05 2008-06-04 Formulations and methods for culturing embryonic stem cells
EP08761727A EP2155859A4 (en) 2007-06-05 2008-06-04 FORMULATIONS AND METHODS FOR CULTIVATING EMBRYONIC STEM CELLS
CA002689321A CA2689321A1 (en) 2007-06-05 2008-06-04 Formulations and methods for culturing embryonic stem cells
AU2008259726A AU2008259726A1 (en) 2007-06-05 2008-06-04 Formulations and methods for culturing embryonic stem cells
US12/632,057 US20100081200A1 (en) 2007-06-05 2009-12-07 Formulations and methods for culturing stem cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20075417A FI20075417A0 (sv) 2007-06-05 2007-06-05 Formulationer och förfaranden för odling av embryonala stamceller

Publications (1)

Publication Number Publication Date
FI20075417A0 true FI20075417A0 (sv) 2007-06-05

Family

ID=38212388

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20075417A FI20075417A0 (sv) 2007-06-05 2007-06-05 Formulationer och förfaranden för odling av embryonala stamceller

Country Status (8)

Country Link
US (1) US20100081200A1 (sv)
EP (1) EP2155859A4 (sv)
JP (1) JP2010528642A (sv)
KR (1) KR20100025569A (sv)
AU (1) AU2008259726A1 (sv)
CA (1) CA2689321A1 (sv)
FI (1) FI20075417A0 (sv)
WO (1) WO2008148938A1 (sv)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20030376A1 (it) 2003-07-31 2005-02-01 Univ Roma Procedimento per l'isolamento e l'espansione di cellule staminali cardiache da biopsia.
US11660317B2 (en) 2004-11-08 2023-05-30 The Johns Hopkins University Compositions comprising cardiosphere-derived cells for use in cell therapy
US8871752B2 (en) 2008-02-19 2014-10-28 Sucampo Ag Method for modulating stem cell growth
US9708582B2 (en) 2009-10-13 2017-07-18 Stemcell Technologies Inc. Method of differentiating stem cells
AU2010306377B2 (en) * 2009-10-13 2015-01-22 Stemcell Technologies Canada Inc. Manipulation of osmolality for differentiating stem cells
EP4166652A1 (en) * 2009-11-12 2023-04-19 Technion Research & Development Foundation Ltd. Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
FI20096288A0 (sv) * 2009-12-04 2009-12-04 Kristiina Rajala Formulationer och förfaranden för odling av stamceller
KR101169701B1 (ko) * 2010-02-26 2012-07-30 (주) 아크스템 자하거 추출물을 함유하는 세포보존제
US9249392B2 (en) * 2010-04-30 2016-02-02 Cedars-Sinai Medical Center Methods and compositions for maintaining genomic stability in cultured stem cells
US9845457B2 (en) 2010-04-30 2017-12-19 Cedars-Sinai Medical Center Maintenance of genomic stability in cultured stem cells
WO2012103098A2 (en) * 2011-01-24 2012-08-02 Immunepath, Inc. Compositions and methods for treating hematological cytopenias
DK2737056T3 (en) 2011-07-29 2018-05-22 Cellular Dynamics Int Inc Metabolic maturation in stem cell-derived tissue cells
WO2013063046A1 (en) 2011-10-24 2013-05-02 Research Development Foundation Methods for increasing insulin secretion by co-stimulation of corticotropin-releasing factor receptors
EP2861238A4 (en) 2012-06-05 2016-03-16 Capricor Inc OPTIMIZED METHODS FOR GENERATING CARDIAC STEM CELLS FROM CARDIAC TISSUE AND THEIR USE IN CARDIAC THERAPY
DE102012213838A1 (de) * 2012-08-03 2014-02-06 Katharina Pachmann Verfahren zur Kultivierung einer Subpopulation zirkulierender epithelialer Tumorzellen aus einer Körperflüssigkeit
EP2882445B1 (en) 2012-08-13 2019-04-24 Cedars-Sinai Medical Center Exosomes and micro-ribonucleic acids for tissue regeneration
WO2014179198A1 (en) * 2013-04-29 2014-11-06 Wisconsin Alumni Research Foundation Methods for producing insulin-secreting beta cells from human pluripotent stem cells
WO2014197421A1 (en) 2013-06-05 2014-12-11 Biotime, Inc. Compositions and methods for induced tissue regeneration in mammalian species
US11078462B2 (en) 2014-02-18 2021-08-03 ReCyte Therapeutics, Inc. Perivascular stromal cells from primate pluripotent stem cells
US10240127B2 (en) 2014-07-03 2019-03-26 ReCyte Therapeutics, Inc. Exosomes from clonal progenitor cells
AU2015327812B2 (en) 2014-10-03 2021-04-15 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy
US10384207B2 (en) 2015-07-21 2019-08-20 Neuro Probe Incorporated Assay apparatus and methods
WO2017123662A1 (en) 2016-01-11 2017-07-20 Cedars-Sinai Medical Center Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction
US11351200B2 (en) 2016-06-03 2022-06-07 Cedars-Sinai Medical Center CDC-derived exosomes for treatment of ventricular tachyarrythmias
WO2018057542A1 (en) 2016-09-20 2018-03-29 Cedars-Sinai Medical Center Cardiosphere-derived cells and their extracellular vesicles to retard or reverse aging and age-related disorders
AU2018255346B2 (en) 2017-04-19 2024-05-02 Capricor Inc Methods and compositions for treating skeletal muscular dystrophy
WO2019126068A1 (en) 2017-12-20 2019-06-27 Cedars-Sinai Medical Center Engineered extracellular vesicles for enhanced tissue delivery
CN111944752B (zh) * 2020-08-28 2021-09-03 广州同康生物科技有限公司 骨骼肌干细胞无血清培养基及其制备方法
JPWO2023286772A1 (sv) * 2021-07-12 2023-01-19

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7101837B1 (en) * 1995-01-24 2006-09-05 Martinex R & D Inc. Recombinant human alpha-fetoprotein as a cell proliferative agent
AU6125396A (en) * 1995-06-07 1996-12-30 Novartis Ag Serum-free media for primitive hematopoietic cells and metho ds of use thereof
GB9828379D0 (en) * 1998-12-22 1999-02-17 Unilever Plc Skin care composition
US7439064B2 (en) * 2000-03-09 2008-10-21 Wicell Research Institute, Inc. Cultivation of human embryonic stem cells in the absence of feeder cells or without conditioned medium
GB0304799D0 (en) * 2003-03-03 2003-04-09 Glaxosmithkline Biolog Sa Novel method
WO2005070120A2 (en) * 2004-01-09 2005-08-04 Serologicals Investment Company, Inc. Cell culture media
MX2007002390A (es) * 2004-09-08 2007-04-23 Wisconsin Alumni Res Found Medio y cultivo de celulas progenitoras embrionarias.
NZ553235A (en) * 2004-09-08 2009-11-27 Wisconsin Alumni Res Found Culturing human pluripotent stem cells

Also Published As

Publication number Publication date
EP2155859A4 (en) 2010-06-30
WO2008148938A1 (en) 2008-12-11
EP2155859A1 (en) 2010-02-24
US20100081200A1 (en) 2010-04-01
KR20100025569A (ko) 2010-03-09
CA2689321A1 (en) 2008-12-11
JP2010528642A (ja) 2010-08-26
AU2008259726A1 (en) 2008-12-11

Similar Documents

Publication Publication Date Title
FI20075417A0 (sv) Formulationer och förfaranden för odling av embryonala stamceller
FI20096288A0 (sv) Formulationer och förfaranden för odling av stamceller
DK3192865T3 (da) Enkelt pluripotent stamcelle-kultur
SE0950586L (sv) Förbättrad odling av stamceller
ZA201606403B (en) Pluripotent stem cell culture on micro-carriers
DK2574677T3 (da) Fremgangsmåder til celledyrkning
DK3121266T3 (da) Oligopeptid-frie cellekulturmedier
PL2240572T3 (pl) Wykorzystanie rna dla przeprogramowania komórek somatycznych
EP2145000A4 (en) REPROGRAMMING SOMATIC CELLS
DK2185693T3 (da) Differentiering af humane embryoniske stamceller
PL2046946T3 (pl) Hodowla pluripotencjalnych komórek macierzystych
BRPI0716762A2 (pt) melhorias da cultura celular
DK2562248T3 (da) Differentiering af humane embryonale stamceller
HK1171790A1 (zh) 用於 蛋白表達的細胞培養基
DK2614141T3 (da) Hidtil ukendte fremgangsmåder og dyrkningsmedier til dyrkning af pluripotente stamceller
BRPI1011127A2 (pt) métodos para o cultivo de células tronco e células progenitoras
DK3399019T3 (da) Fremgangsmåder til bevaring af kulturs levedygtighed
BRPI0814310A2 (pt) Enzima lecitina-colesterol acetiltransferase modificada
DE602007008627D1 (de) Zellkulturmedium
FI20105297A (sv) Förfaranden för stratifiering och lagring av somatiska embryon
IT1394412B1 (it) Procedimento per l'essiccazione di biomassa algale
FI20065762A0 (sv) Förfarande för kontroll av tillväxt i cellkultur
FI20095223A (sv) Inredningselement och förfarande för framställning därav
SE0701400L (sv) Odlingssystem
FI20085724A0 (sv) Cellodling